Abstract
Patients with chronic obstructive pulmonary disease (COPD) have an independent increased risk of cardiovascular (CV) disease. Cardiovascular risk (CVR) assessment should be offered to all patients with COPD, according to the new Dutch CVR management (CVRM) guideline (May 2019). To evaluate the impact of the new CVRM guideline on the care of patients with COPD in primary care. A retrospective study took place within five primary healthcare centres located in The Netherlands. In accordance with the guideline, the CVR of all patients with COPD was estimated and categorised. Data from 2014-2019 were used for the qualitative risk assessment based on comorbidities, and the quantitative Systematic Coronary Risk Evaluation (SCORE). In addition, the guideline-based follow-up was investigated. Of the 391 patients with COPD, 84.1% (n = 329) had complete data on CVR assessment: 90.3% (n = 297) had a (very) high risk, and 9.7% (n = 32) a low-to-moderate risk. Of the patients with (very) high risk, 73.4% (n = 218) received guideline-based follow-up (primary care: 95.4%, secondary care: 4.6%). In 15.9% (n = 62) of all patients with COPD, the CVR profile was not measured and of the (very) high-risk patients, 26.6% (n = 79) were not enroled in ...Continue Reading
References
Aug 23, 2005·Proceedings of the American Thoracic Society·Don D Sin, S F Paul Man
Oct 21, 2005·Chest·Laetitia HuiartSamy Suissa
May 14, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Robert M ShavelleDavid J Strauss
Feb 6, 2010·Respiration; International Review of Thoracic Diseases·Mario CazzolaGianluca Biscione
Jul 31, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Irene DrubbelMattijs E Numans
Sep 25, 2012·European Journal of Preventive Cardiology·Sabine LudtJoachim Szecsenyi
Jun 1, 2013·Chest·Hana MüllerovaDouglas W Mapel
Jul 6, 2014·Lancet·Ursula E BauerBarbara A Bowman
Apr 30, 2015·European Heart Journal·Lies LahousseGuy G Brusselle
Jul 26, 2015·The Lancet. Respiratory Medicine·Wenjia ChenJ Mark FitzGerald
Nov 2, 2015·Respiratory Investigation·Netsanet A NegewoPeter G Gibson
Feb 26, 2016·COPD·Nanca Cebron LipovecAnnemie M W J Schols
Oct 14, 2016·Lancet·UNKNOWN GBD 2015 Mortality and Causes of Death Collaborators
Sep 2, 2017·Circulation Research·Philip JosephSalim Yusuf
Jan 23, 2018·Therapeutic Advances in Respiratory Disease·Ann D MorganJennifer K Quint
Feb 14, 2018·Thorax·Ann D MorganJennifer K Quint
Apr 7, 2018·Thorax·Fernando Sergio Leitao Filho, Don D Sin
Apr 14, 2019·Clinical Science·Kurt BrassingtonRoss Vlahos